
Platycodin D2
CAS No. 66663-90-9
Platycodin D2 ( —— )
产品货号. M29216 CAS No. 66663-90-9
Platycodin D2 是一种溶血性较低的皂苷,可改善小鼠对乙型肝炎表面抗原的特异性细胞和体液反应,可安全地用作引发 Th1 和 Th2 免疫反应的佐剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1231 | 有现货 |
![]() ![]() |
10MG | ¥1806 | 有现货 |
![]() ![]() |
25MG | ¥3038 | 有现货 |
![]() ![]() |
50MG | ¥4512 | 有现货 |
![]() ![]() |
100MG | ¥6342 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Platycodin D2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Platycodin D2 是一种溶血性较低的皂苷,可改善小鼠对乙型肝炎表面抗原的特异性细胞和体液反应,可安全地用作引发 Th1 和 Th2 免疫反应的佐剂。
-
产品描述Platycodin D2 , a less hemolytic saponin, can improve specific cellular and humoral responses to hepatitis B surface antigen in mice, it could be safely used as adjuvant eliciting Th1 and Th2 immune responses.(In Vitro):Platycodin D2 exhibited significant inhibition on the proliferation of five kinds of cultured human tumor cell lines(ED50: ca. 4 - 18 microg/mL), i. e., A549 (non-small cell lung), SK-OV-3 (ovary), SK-MEL-2 (melanoma), XF498 (central nerve system) and HCT-15 (colon), in vitro.(In Vivo):Platycodin D2 significantly increased the concanavalin A (Con A)-, lipopolysaccharide (LPS)-, and HBsAg-induced splenocyte proliferation in HBsAg-immunized mice (P<0.05, P<0.01, and P<0.001, resp.). HBsAg-specific IgG, IgG1, IgG2a, and IgG2b antibody titers in the serum were also markedly enhanced by Platycodin D2 compared to the HBsAg control group (P<0.01 or P<0.001). Moreover, Platycodin D2 significantly promoted the production of Th1 (IL-2 and IFN-gamma) and Th2 (IL-4 and IL-10) cytokines from splenocytes in the HBsAg-immunized mice (P<0.001). The adjuvant potential of Platycodin D2 on splenocyte proliferation, serum HBsAg-specific IgG2a and IgG2b antibody response, as well as Th1-cytokine secretion from splenocytes in the HBsAg-immunized mice was higher than that of Alum.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Apoptosis
-
靶点IL Receptor
-
受体IL Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number66663-90-9
-
分子量1387.476
-
分子式C63H102O33
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (72.07 mM)
-
SMILESC[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)CO[C@H]2OC(=O)[C@]23CCC(C)(C)C[C@H]2C2=CC[C@@H]4[C@@]5(C)C[C@H](O)[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)C(CO)(CO)[C@@H]5CC[C@@]4(C)[C@]2(C)C[C@H]3O)[C@H](O)[C@H](O)[C@H]1O[C@@H]1OC[C@@H](O)[C@H](O[C@@H]2OC[C@](O)(CO)[C@H]2O)[C@H]1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
YQ128
YQ128是第二代NLRP3(NOD样受体P3)炎症小体的有效选择性抑制剂(IC50为0.30 μM),具有抗炎活性。
-
Vunakizumab
Vunakizumab (Anti-Human IL17A Recombinant Antibody) 是一种重组的人源化 IgGκ 单克隆抗体,可以靶向 IL-17A 并抑制其与 IL-17 受体的相互作用。Vunakizumab 可用于研究银屑病关节炎、强直性脊柱炎、多发性硬化症和炎症性关节炎等自身免疫性疾病。
-
Diallyl disulfide
二烯丙基二硫化物具有抗肿瘤作用,miR-200b和miR-22可增强该作用。